Beta Bionics reported Q4 2025 sales growth, but analysts raised concerns about valuation and slower patient starts.
Analysts downgraded Beta Bionics (Nasdaq:BBNX) to "Neutral" following preliminary fourth-quarter results that fell shy of ...
The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...
In a week packed with noteworthy debuts in Las Vegas, these 24 innovations stand out as the most promising bets for what's ...
Dephy came to CES 2026 to debut their new robotic sneakers called the Sidekick, which deliver a new way of mobility for those ...
Interesting Engineering on MSN
Video: Touch-sensitive humanoid robot inspired by human body intelligence unveiled
The GENE.01 humanoid robot is equipped with a full-body tactile skin, a distributed network of touch and force sensors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback